MEDP
Medpace Holdings, Inc. · Healthcare · Medical - Diagnostics & Research
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 +0.5% · 净新建仓位 -4.5% · 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 45.76K | $27.51M | n/a | −1 |
| Q2 2026 | 129 | -10 | 16.75M | $8.87B | +3 | −14 |
| Q1 2026 | 143 | -2 | 15.75M | $7.54B | +5 | −8 |
| Q4 2025 | 145 | 0 | 17.01M | $9.56B | +1 | n/a |
| Q3 2025 | 22 | 0 | 10.56M | $5.42B | +1 | −2 |
| Q2 2025 | 20 | +1 | 9.67M | $3.03B | +1 | n/a |
| Q1 2025 | 16 | -1 | 3.77M | $1.14B | n/a | −1 |
| Q4 2024 | 17 | +1 | 4.06M | $1.35B | +1 | n/a |
| Q3 2024 | 15 | -1 | 3.56M | $1.19B | n/a | −1 |
| Q2 2024 | 16 | n/a | 3.05M | $1.26B | n/a | n/a |
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 2.36M | -4.4% | $1.21B | 0.0% | ▼ Trim | 2 | SEC ↗ ×18 |
| 2 | The Vanguard Group ✦ (被动) | 2.28M | -4.5% | $1.17B | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 3 | AQR Capital Management ✦ | 1.03M | +65.1% | $518.17M | 0.3% | ▲ Add | 6 | SEC ↗ ×6 |
| 4 | State Street Global Advisors ✦ (被动) | 673.14K | -4.8% | $346.10M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 5 | Geode Capital Management ✦ (被动) | 642.67K | +0.7% | $330.47M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 6 | D. E. Shaw & Co. ✦ | 600.14K | +74.7% | $308.57M | 0.3% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | Baillie Gifford ✦ | 584.80K | +12.0% | $300.68M | 0.2% | ▲ Add | 6 | SEC ↗ ×4 |
| 8 | Morgan Stanley ✦ | 510.92K | n/a | $262.70M | 0.0% | n/c | 1 | SEC ↗ ×9 |
| 9 | Renaissance Technologies ✦ | 493.59K | -27.2% | $253.78M | 0.3% | ▼ Trim | 6 | SEC ↗ |
| 10 | JPMorgan Chase ✦ | 355.71K | n/a | $182.89M | 0.0% | n/c | 1 | SEC ↗ ×16 |
| 11 | Arrowstreet Capital ✦ | 314.15K | +205.8% | $161.52M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 12 | Goldman Sachs Group ✦ | 180.40K | n/a | $92.75M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 13 | Fisher Asset Management ✦ | 137.75K | +9.9% | $70.82M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 14 | Millennium Management ✦ | 116.61K | -66.2% | $59.96M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 102.33K | -0.9% | $52.61M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 16 | Two Sigma Investments ✦ | 85.37K | -68.0% | $43.89M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 17 | Bridgewater Associates ✦ | 33.23K | 新增 | $17.09M | 0.1% | New | 1 | SEC ↗ |
| 18 | Citadel Advisors ✦ | 22.91K | -66.8% | $11.78M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | Gotham Asset Management ✦ | 16.68K | +16.0% | $8.57M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 20 | Wellington Management ✦ | 11.60K | -57.8% | $5.97M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 21 | Fidelity (FMR) ✦ | 7.81K | -71.0% | $4.02M | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 22 | Marshall Wace ✦ | 6.59K | +580.3% | $3.39M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Bridgewater Associates | $17.09M | 0.1% |
已清仓
| Norges Bank | $66.60M | 曾为 0.0% |
| Capital World Investors | $3.51M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 724 持有人, 23.89M 股份, $10.71B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Officer, Director, 10% owner · 21.97K 股 · $13.74M
Officer, Director, 10% owner · 26.70K 股 · $16.58M
Officer, Director, 10% owner · 2.41K 股 · $1.49M
Officer, Director, 10% owner · 154 股 · $95,572
Officer, Director, 10% owner · 27.83K 股 · $17.29M
Officer, Director, 10% owner · 16.08K 股 · $10.11M
Officer, Director, 10% owner · 49.02K 股 · $30.79M
Officer, Director, 10% owner · 21.88K 股 · $13.64M
Officer, Director, 10% owner · 10.88K 股 · $6.75M
Officer, Director, 10% owner · 8.77K 股 · $5.45M
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
19.1% 占股份类别 · 查看 SEC 原始申报文件 ↗